Ironwood Pharmaceuticals, Inc. (IRWD) | Stock price, performance, AI analysis | Thematic | AI powered fundamental research and development platform

Ironwood Pharmaceuticals, Inc. (IRWD)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation

Ask a question about Ironwood Pharmaceuticals, Inc. (IRWD)

Company Performance

Current Price

as of Oct 16, 2024

$4.50

P/E Ratio

104.17

Market Cap

$718.83M

Description

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Metrics

Overview

HQBoston, MA
SectorHealth Technology
IndustryPharmaceuticals: Major
TickerIRWD
Price$4.5+2.51%

Trading Information

Market Cap$718.83M
Float97.40%
Average Daily Volume (1m)1,564,701
Average Daily Volume (3m)1,924,612
EPS$0.06

Company

Revenue$400.57M
Rev Growth (1yr)-12.09%
Net Income-$0.86M
Gross Margin99.46%
EBITDA Margin29.19%
EBITDA$27.55M

EV$1.57B
EV/Revenue3.92
P/E104.17
P/S1.79
P/BN/A

Documents

Earnings Calls

Earnings Report 2024Q2

Earnings Report 2024Q1

Earnings Report 2023Q4

Earnings Report (2023-11-09)

Earnings Report (2023-08-08)

Factset

Factset Business Description

Wikipedia

Ironwood_Pharmaceuticals

Factset Street Account

StreetAccount Earnings Call Q&A Summary: Ironwood Pharmaceuticals Q3 ($9.49, +0.25) (2023-11-09T15:13:28Z)

Ironwood Pharmaceuticals reports Q3 GAAP EPS $0.09 vs FactSet $0.20 [5 est, $0.12-0.39] ($9.23, 0.00) (2023-11-09T12:08:08Z)

Ironwood Pharmaceuticals releases new IBS-C and CIC data at the American College of Gastroenterology 2023 annual scientific meeting ($9.23, 0.00) (2023-10-23T11:32:10Z)

Ironwood Pharmaceuticals initiated buy at Jefferies ($9.23, 0.00) (2023-11-09T10:22:32Z)